References
- 1. Zhu W, He X, Cheng K, Zhang L, Chen D, Wang X, et al. Ankylosing spondylitis: etiology, pathogenesis, and treatments. Bone Res. 2019 7(22). DOI: 10.1038/s41413-019-0057-810.1038/s41413-019-0057-8680488231666997
- 2. Wang R, Ward MM. Epidemiology of axial spondyloarthritis: un update. Curr Opin Rheumatol. 2018 March;30(2):137-43. DOI: 10.1097/BOR.000000000000047510.1097/BOR.0000000000000475581120329227352
- 3. Ranganathan V, Gracey E, Brown MA, Inman RD, Haroon N. Pathogenesis of ankylosing spondylitis - recent advances and future directions. Nat Rev Rheumatol. 2017 Jun;13(6):359-67. DOI: 10.1038/nrrheum.2017.5610.1038/nrrheum.2017.5628446810
- 4. Costello ME, Ciccia F, Willner D, Warrington N, Robinson PC, et al. Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis. Arthritis Rheumatol. 2015 Mar;67(3):686-91. DOI: 10.1002/art.3896710.1002/art.3896725417597
- 5. Tito RY, Cypers H, Joossens M, Varkas G, Van Praet L, Glorieu E, et al. Brief Report: Dialister as a Microbial Marker of Disease Activity in Spondyloarthritis. Arthritis Rheumatol. 2017 69(1):114-21. DOI: 10.1002/art.3980210.1002/art.3980227390077
- 6. Browne HP, Forster SC, Anonye BO, Kumar N, Neville BA, Stares MD, et al. Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation. Nature. 2016 May;533(7604):543-546. DOI: 10.1038/nature1764510.1038/nature17645489068127144353
- 7. Cullen CM, Aneja KK, Beyhan S, Cho CE, Woloszynek S, Convertino M, et al. Emerging Priorities for Microbiome Research. Front Microbiol. 2020 Feb;19(11):136. DOI: 10.3389/fmicb.2020.0013610.3389/fmicb.2020.00136704232232140140
- 8. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984 27:361-8. DOI: 10.1002/art.178027040110.1002/art.17802704016231933
- 9. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011 Jun;12(6):R60. DOI: 10.1186/gb-2011-12-6-r6010.1186/gb-2011-12-6-r60321884821702898
- 10. Kashyap PC, Chia N, Nelson H, Segal E, Elinav E. Microbiome at the Frontier of Personalized Medicine. Mayo Clin Proc. 2017 Dec;92(12):1855-64. DOI: 10.1016/j.mayocp.2017.10.00410.1016/j.mayocp.2017.10.004573033729202942
- 11. Cardoneanu A, Cozma S, Rezus C, Petrariu F, Burlui AM, Rezus E. Characteristics of the intestinal micro-biome in ankylosing spondylitis. Exp Ther Med. 2021 Jul;22(1):676. DOI: 10.3892/etm.2021.1010810.3892/etm.2021.10108811212933986841
- 12. Pollock J, Glendinning L, Wisedchanwet T, Watson M. The madness of microbiome: attempting to find consensus “best practice” for 16S microbiome studies. Appl Environ Microbiol. 2018 84(7):e02627-17. DOI: 10.1128/AEM.02627-1710.1128/AEM.02627-17586182129427429
- 13. Bharti R, Grimm DG. Current challenges and best-practice protocols for microbiome analysis. Brief Bioin-form. 2021 22(1):178-93. DOI: 10.1093/bib/bbz15510.1093/bib/bbz155782083931848574
- 14. Allali I, Arnold JW, Roach J, Cadenas MB, Butz N, Hassan HM, et al. A comparison of sequencing platforms and bioinformatics pipelines for compositional analysis of the gut microbiome. BMC Microbiol. 2017 Sep;17(1):194. DOI: 10.1186/s12866-017-1101-810.1186/s12866-017-1101-8559803928903732
- 15. Salipante SJ, Kawashima T, Rosenthal C, Hoogestraat DR, Cummings LA, Sengupta DJ, et al. Performance comparison of Illumina and ion torrent next-generation sequencing platforms for 16S rRNA-based bacterial community profiling. Appl Environ Microbiol. 2014 Dec;80(24):7583-91. DOI: 10.1128/AEM.02206-1410.1128/AEM.02206-14424921525261520
- 16. Mas-Lloret J, Obón-Santacana M, Ibá-ez-Sanz G, Guinó E, Pato ML, Rodriguez-Moranta F, et al. Gut microbiome diversity detected by high-coverage 16S and shotgun sequencing of paired stool and colon sample. Sci Data. 2020 Mar;7(1):92. DOI: 10.1038/s41597-020-0427-510.1038/s41597-020-0427-5707595032179734
- 17. Watts GS, Youens-Clark K, Slepian MJ, Wolk DM, Oshiro MM, Metzger GS, et al. 16S rRNA gene sequencing on a benchtop sequencer: accuracy for identification of clinically important bacteria. J Appl Microbiol. 2017 Dec;123(6):1584-96. DOI: 10.1111/jam.1359010.1111/jam.13590576550528940494
- 18. Soergel DA, Dey N, Knight R, Brenner SE. Selection of primers for optimal taxonomic classification of environmental 16S rRNA gene sequences. ISME J. 2012 Jul;6(7):1440-4. DOI: 10.1038/ismej.2011.20810.1038/ismej.2011.208337964222237546
- 19. Mizrahi-Man O, Davenport ER, Gilad Y. Taxonomic classification of bacterial 16S rRNA genes using short sequencing reads: evaluation of effective study designs. PLoS One. 2013 8(1):e53608. DOI: 10.1371/journal. pone.0053608
- 20. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010 May;7(5):335-6. DOI: 10.1038/nmeth.f.30310.1038/nmeth.f.303315657320383131
- 21. Tang Q, Jin G, Wang G, Liu T, Liu X, Wang B et al. Current Sampling Methods for Gut Microbiota: A Call for More Precise Devices. Front Cell Infect Microbiol. 2020 10:151. DOI: 10.3389/fcimb.2020.0015110.3389/fcimb.2020.00151716108732328469
- 22. Lavelle A, Lennon G, O’Sullivan O, Docherty N, Balfe A, Maguire A, et al. Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers. Gut. 2015 Oct;64(10):1553-61. DOI: 10.1136/gutjnl-2014-30787310.1136/gutjnl-2014-307873460225225596182
- 23. Penington JS, Penno MAS, Ngui KM, Ajami NJ, Roth-Schulze AJ, Wilcox SA, et al. Influence of fecal collection conditions and 16S rRNA gene sequencing at two centers on human gut microbiota analysis. Sci Rep. 2018 Mar;8(1):4386. DOI: 10.1038/s41598-018-22491-710.1038/s41598-018-22491-7584757329531234
- 24. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009 Dec;326(5960):1694-7. DOI: 10.1126/science.117748610.1126/science.1177486360244419892944
- 25. Berg G, Rybakova D, Fischer D, Cernava T, Vergès MC, Charles T, et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome. 2020 Jun;8(1):103. DOI: 10.1186/s40168-020-00875-010.1186/s40168-020-00875-0732952332605663
- 26. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, et al. Enterotypes of the human gut microbiome. Nature. 2011 May;473(7346):174-80. DOI: 10.1038/nature0994410.1038/nature09944372864721508958
- 27. Shin NR, Whon TW, Bae JW. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 2015 Sep;33(9):496-503. DOI: 10.1016/j. tibtech.2015.06.011
- 28. Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. The Role of Enterobacteriaceae in gut microbiota dysbiosis in inflammatory bowel diseases. Microorganisms. 2021 Mar;9(4):697. DOI: 10.3390/microorganisms904069710.3390/microorganisms9040697806630433801755
- 29. Chen Z, Qi J, Wei Q, Zheng X, Wu X, Li X, et al. Variations in gut microbial profiles in ankylosing spondylitis: disease phenotype-related dysbiosis. Ann Transl Med. 2019 Oct;7(20):571. DOI: 10.21037/atm.2019.09.4110.21037/atm.2019.09.41686174031807552
- 30. Falony G, Joossens M, Vieira-Silva S, Wang J, Darzi Y, Faust K, et al. Population-level analysis of gut micro-biome variation. Science. 2016 Apr;352(6285):560-4. DOI: 10.1126/science.aad350310.1126/science.aad350327126039
- 31. Aguirre de Cárcer D. The human gut pan-microbiome presents a compositional core formed by discrete phylogenetic units. Sci Rep. 2018 Sep;8(1):14069. DOI: 10.1038/s41598-018-32221-810.1038/s41598-018-32221-8614591730232462
- 32. Zhang L, Han R, Zhang X, Fang G, Chen J, Li J, et al. Fecal microbiota in patients with ankylosing spondylitis: Correlation with dietary factors and disease activity. Clin Chim Acta. 2019 Oct;497:189-96. DOI: 10.1016/j. cca.2019.07.038
- 33. Hooks KB, O’Malley MA. Dysbiosis and its discontents. mBio. 2017 Oct;8(5):e01492-17. DOI: 10.1128/mBio.01492-1710.1128/mBio.01492-17563569129018121
- 34. Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E. Dysbiosis and the immune system. Nat Rev Immunol. 2017 Apr;17(4):219-32. DOI: 10.1038/nri.2017.710.1038/nri.2017.728260787
- 35. Harkins P, Burke E, Swales C, Silman A. ‘All disease begins in the gut’-the role of the intestinal microbiome in ankylosing spondylitis. Rheumatol Adv Pract. 2021 Sep;5(3):rkab063. DOI: 10.1093/rap/rkab06310.1093/rap/rkab063845299934557624